Literatur > Helga Konrad
zurück

  • Wollina U, Pabst F, Schönlebe J, Abdel-Naser MB, Konrad H, Gruner M, Haroske G, Klemm E, Schreiber G. Side-effects of topical androgenic and anabolic substances and steroids. A short review. Acta Dermatovenerol Alp Panonica Adriat. 2007 Sep; 16(3):117-22.
  • Wollina U, Konrad H, Petersen S. Botulinum toxin in dermatology - beyond wrinkles and sweat. J Cosmet Dermatol. 2005 Dec; 4(4):223-7.
  • Köstler E, Konrad H, Wollina U. Treatment of dystrophic calcification in leg ulcers. Int Wound J. 2005 Sep; 2(3):239.
  • Konrad H, Wollina U. [Black discoloration of nails in polycythaemia vera] J Dtsch Dermatol Ges. 2005 Sep;3(9):723-5.
  • Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol. 2005; 6(3):141-50.
  • Wollina U, Abdel Naser MB, Hansel G, Helm C, Koch A, Konrad H, Schönlebe J, Unger L, Köstler E. Leg ulcers are a diagnostic and therapeutic challenge. Int J Low Extrem Wounds. 2005 Jun; 4(2):97-104.
  • Wollina U, Konrad H, Schönlebe J. Lipoid proteinosis. Acta Dermatovenerol Alp Panonica Adriat. 2004 Dec; 13(4):131-4.
  • Wollina U, Degen KW, Konrad H, Schönlebe J. Itching stretch marks and bullous lesions in a pregnant woman. Int J Dermatol. 2004 Oct; 43(10):752-4.
  • Wollina U, Konrad H, Schmidt WD, Haroske G, Astafeva LG, Fassler D. Response of spider leg veins to pulsed diode laser (810 nm): a clinical, histological and remission spectroscopy study. J Cosmet Laser Ther. 2003 Dec; 5(3-4):154-62.
  • Wollina U, Dummer R, Brockmeyer NH, Konrad H, Busch JO, Kaatz M, Knopf B, Koch HJ, Hauschild A. Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma. Cancer. 2003 Sep 1; 98(5):993-1001.
  • Konrad H, Karamfilov T, Wollina U. Intracutaneous botulinum toxin A versus ablative therapy of Hailey-Hailey disease--a case report. J Cosmet Laser Ther. 2001 Dec; 3(4):181-4.
  • Wollina U, Konrad H. Botulinum toxin A in anal fissures: a modified technique. J Eur Acad Dermatol Venereol. 2002 Sep; 16(5):469-71.
  • Wollina U, Konrad H. Treatment of recalcitrant psoriatic arthritis with anti-tumor necrosis factor-alpha antibody. J Eur Acad Dermatol Venereol. 2002 Mar; 16(2):127-9.
  • Wollina U, Karamfilov T, Konrad H. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol. 2002 Apr; 46(4):536-40.
  • Wollina U, Konrad H, Graefe T. Ulcerative lichen planus: a case responding to recombinant platelet-derived growth factor BB and immunosuppression. Acta Derm Venereol. 2001 Oct-Nov; 81(5):364-5.
  • Wollina U, Konrad H, Karamfilov T. Treatment of common warts and actinic keratoses by Er:YAG laser. J Cutan Laser Ther. 2001 Jun;3(2):63-6.
  • Wollina U, Liebold K, Konrad H. Treatment of chronic radiation ulcers with recombinant platelet-derived growth factor and a hydrophilic copolymer membrane. J Eur Acad Dermatol Venereol. 2001 Sep; 15(5):455-7.
  • Graefe T, Konrad H, Barta U, Wollina U, Elsner P. Successful ultraviolet A1 treatment of cutaneous sarcoidosis. Br J Dermatol. 2001 Aug; 145(2):354-5. No abstract available.
  • Wollina U, Konrad H, Fischer T. Recessive epidermolysis bullosa dystrophicans (Hallopeau-Siemens)--improvement of wound healing by autologous epidermal grafts on an esterified hyaluronic acid membrane. J Dermatol. 2001 Apr; 28(4):217-20.
  • Wollina U, Konrad H, Graefe T, Thiele J. Botulinum toxin A for focal hyperhidrosis in leg amputees: a case report. Acta Derm Venereol. 2000 May; 80(3):226-7.